MedAI Verdict
All comparisons

Reteta vs ScribeMD

Deployment comes first. Reteta says it is the only ambient AI company offering customizable on-premises and private cloud deployments, a vendor claim, while ScribeMD states it is hosted on AWS across multiple zones. A health system that must keep encounter audio inside its own network can strike ScribeMD from the list. Reteta also offers a 15-day free trial before its paid plans and produces SOAP notes with ICD-10 and CPT coding. ScribeMD, run by EE Dojo, Inc., lists an individual doctor at "free forever" without saying what that tier includes, and groups get a custom quote. It names Epic, Cerner, athenahealth and Veradigm, says BAAs are in place and says patient data is never used to train models. Its SOC 2 badge carries no type. ScribeMD's free tier costs an individual doctor nothing to try, and the pricing page leaves its limits unstated.

AI medical scribes · Reviewed November 2, 2026

Reteta logo

Reteta

by Reteta

Ambient AI scribe that produces SOAP notes and ICD-10 and CPT coding suggestions for clinicians.

ScribeMD logo

ScribeMD

by EE Dojo, Inc.

AI medical scribe that listens to visits, drafts clinical notes and syncs them to the EHR.

When to pick each one

Reteta

  • On-premises and private cloud deployment (vendor claim)
  • Free 15-day trial offered
  • SOAP notes with ICD-10 and CPT coding
Read the full Reteta review

ScribeMD

  • Individual doctor tier listed as free forever
  • Epic, Cerner, athenahealth and Veradigm named
  • BAAs in place, data not used for training
Read the full ScribeMD review

Score

Each row shows points earned of points available under the published rubric.

Reteta

45of 100

Solid choice

ScribeMD

52of 100

Solid choice
Score by dimension for Reteta and ScribeMD
DimensionRetetaScribeMDDifference
HIPAA / SOC2 / BAA7.8 / 1313 / 13-5.2
EHR integrations (count)10.5 / 2110.5 / 210
Top-3 EHR coverage (Epic / Oracle / Athena)12 / 1212 / 120
Bidirectional write-back0 / 5.20 / 5.20
Peer-reviewed papers0 / 70 / 70
RCT / meta-analysis / systematic review0 / 30 / 30
Funding & adoption signal3 / 123 / 120
Pricing transparency5 / 55 / 50
Years in market0 / 60 / 60

Scroll horizontally to see every column.

How scores are computed

Pricing

Reteta

TierMonthlyAnnualNotes
Starter, monthly billing$99n/a15 ambient scribing sessions per month, basic SOAP notes, standard EHR integration, 24x7 email support. Free 15 day trial.
Starter, annual billing$89n/aSame Starter tier on annual billing.
Professional, monthly billing$149n/aUnlimited ambient scribing, advanced coding automation, custom specialty templates and priority support.
Professional, annual billing$134n/aSame Professional tier on annual billing. The page says annual billing saves 10%.
Enterprisen/an/aNo public price. EMR integration, volume pricing, analytics dashboard, dedicated account management and 24/7 support.

ScribeMD

TierMonthlyAnnualNotes
Individual doctorn/an/aFree forever, no credit card required. The pricing page does not state what the free tier limits.
Enterprisen/an/aNo public price. Custom per organization for groups, clinics and health systems, with no trial clock or visit limits, a custom contract and a BAA.

Compliance and integrations

Documented from each vendor’s own pages.

SpecRetetaScribeMD
Free tierYesYes
HIPAAYesYes
SOC 2 Type IINo / unverifiedYes
EHR integrationsEpic, Cerner, athenahealth, eClinicalWorksEpic, Cerner, athenahealth, Veradigm
Foundedn/an/a
HQn/an/a

Scroll horizontally to see both columns.

Common questions

Open the full ai medical scribes comparison

The best AI medical scribe for most US physicians is Abridge for hospital systems, Freed AI for solo practice (plans from $39 to $119 per month as of October 2026), Heidi Health for multilingual capture, and DAX Copilot for Microsoft-shop hospitals. Each pick below names its primary EHR integration, pricing model, and the clinician communities that surface it most often. Enterprise scribes are quote-based, with third-party estimates of roughly $208 to $600 per provider per month as of October 2026.